irinotecan

North America

Canada (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN 20MG/ML sol
Rx
iv
L01XX19
IRINOTECAN FOR INJECTION 20MG/ML sol
Rx
iv
L01XX19
IRINOTECAN HYDROCHLORIDE INJECTION 20MG/ML sol
Rx
iv
L01XX19
IRINOTECAN HYDROCHLORIDE INJECTION USP 20MG/ML sol
Rx
iv
L01XX19
IRINOTECAN HYDROCHLORIDE INJECTION USP 20MG/ML sol
Rx
iv
L01XX19
ONIVYDE 4.3MG/ML susp
Rx
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN 20MG/ML sol
02410419
IRINOTECAN FOR INJECTION 20MG/ML sol
02312409
IRINOTECAN HYDROCHLORIDE INJECTION 20MG/ML sol
02412187
IRINOTECAN HYDROCHLORIDE INJECTION USP 20MG/ML sol
02357585
IRINOTECAN HYDROCHLORIDE INJECTION USP 20MG/ML sol
02258218
ONIVYDE 4.3MG/ML susp
02467135
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (60)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTOSAR 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
CAMPTOSAR 300MG/15ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
CAMPTOSAR 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
Y

Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
N

INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Y
Rx
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 20MG/ML inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
Y

Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
N

INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
N
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Y
Rx
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
Y
Rx
INJECTION
L01XX19
ONIVYDE EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML) INJECTABLE, LIPOSOMAL
Y
Rx
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTOSAR 100MG/5ML (20MG/ML) inj
20571/2
NDA
14-06-1996
CAMPTOSAR 300MG/15ML (20MG/ML) inj
20571/3
NDA
05-08-2010
CAMPTOSAR 40MG/2ML (20MG/ML) inj
20571/1
NDA
14-06-1996
IRINOTECAN HYDROCHLORIDE 100MG/5ML inj
200771/3
ANDA
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
79068/2
ANDA
21-11-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78589/2
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
90726/2
ANDA
16-09-2009
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
77219/2
ANDA
20-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
200771/2
ANDA
14-02-2012
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
213278/2
ANDA
02-11-2020
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78188/2
77776/2
ANDA
ANDA
27-02-2008
27-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
212993/2
ANDA
18-11-2019
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
91032/2
ANDA
20-12-2010
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
90016/2
ANDA
28-01-2009
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
77915/2
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
203054/2
ANDA
31-08-2017
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
90675/1
ANDA
16-12-2011
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78953/2
ANDA
15-04-2010
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
206935/2
ANDA
26-05-2017
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78122/2
ANDA
31-10-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
203380/2
ANDA
03-05-2016
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
90137/2
77994/2
ANDA
ANDA
12-11-2009
27-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
208718/2
ANDA
28-12-2018
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78805/2
ANDA
21-04-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
77260/2
90101/3
ANDA
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
78753/2
ANDA
24-12-2008
IRINOTECAN HYDROCHLORIDE 100MG/5ML (20MG/ML) inj
90393/3
ANDA
13-05-2011
IRINOTECAN HYDROCHLORIDE 20MG/ML inj
90393/1
ANDA
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
213278/3
ANDA
02-11-2020
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
203380/3
ANDA
03-05-2016
IRINOTECAN HYDROCHLORIDE 300MG/15ML (20MG/ML) inj
208718/3
ANDA
16-08-2019
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
79068/1
ANDA
21-11-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78589/1
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
90726/1
ANDA
16-09-2009
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
77219/1
ANDA
20-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
200771/1
ANDA
14-02-2012
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
213278/1
ANDA
02-11-2020
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78188/1
77776/1
ANDA
ANDA
27-02-2008
27-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
212993/1
ANDA
18-11-2019
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
91032/1
ANDA
20-12-2010
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
90016/1
ANDA
28-01-2009
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
77915/1
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
203054/1
ANDA
31-08-2017
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
90675/2
ANDA
16-12-2011
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78953/1
ANDA
15-04-2010
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
206935/1
ANDA
26-05-2017
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78122/1
ANDA
31-10-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
203380/1
ANDA
03-05-2016
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
90137/1
77994/1
ANDA
ANDA
12-11-2009
27-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
208718/1
ANDA
28-12-2018
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78805/1
ANDA
21-04-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
77260/1
90101/2
ANDA
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
78753/1
ANDA
24-12-2008
IRINOTECAN HYDROCHLORIDE 40MG/2ML (20MG/ML) inj
90393/2
ANDA
13-05-2011
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
78589/3
ANDA
18-11-2015
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
78796/1
ANDA
27-02-2008
IRINOTECAN HYDROCHLORIDE 500MG/25ML (20MG/ML) inj
90101/1
ANDA
26-11-2008
ONIVYDE EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML) INJECTABLE, LIPOSOMAL
207793/1
NDA
22-10-2015
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HIKMA 20 MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN KABI 20 MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
Rx
-
L01XX19
ONIVYDE 4,3 MG/ML conc for sol for inf
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
136991
07-07-2016
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1-28144
15-04-2009
IRINOTECAN HIKMA 20 MG/ML conc for sol for inf
1-29063
10-03-2010
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1-28288
27-05-2009
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
138425
31-07-2018
ONIVYDE 4,3 MG/ML conc for sol for inf
EU/1/16/1130/001
14-10-2016
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (24)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 20 MG/ML conc for sol for inf
15 mL
2 mL
5 mL
Y
Y
Y


iv
L01XX19
IRINOKABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
N
N
N
N



iv
L01XX19
IRINOLIQUID conc for sol for inf
15 mL
25 mL
5 mL
-
-
-


iv
L01XX19
IRINOLIQUID 150 MG/7,5 ML conc for sol for inf
7,5 mL
-
iv
L01XX19
IRINOLIQUID 40 MG/2 ML conc for sol for inf
2 mL
-
iv
L01XX19
IRINOMYLAN 20 MG/ML conc for sol for inf
2 mL
5 mL
-
-

iv
L01XX19
IRINOSIN 20 MG/ML conc for sol for inf
15 mL
2 mL
2 mL
25 mL
25 mL
5 mL
5 mL
-
N
Y
N
Y
Y
-






iv
L01XX19
IRINOTECAN AB 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
Y
Y
Y
Y
-




iv
L01XX19
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
50 mL
Y
Y
Y
Y
-




iv
L01XX19
IRINOTECAN EG 20 MG/ML conc for sol for inf
2 mL
5 mL
N
N

iv
L01XX19
IRINOTECAN EG 20 MG/ML conc for sol for inj
15 mL
N
iv
L01XX19
IRINOTECAN HIKMA 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
-
-
-
-



iv
L01XX19
IRINOTECAN HIKMA FARMACEUTICA 20 MG/ML conc for sol for inf
2 mL
25 mL
5 mL
Y
Y
N


iv
L01XX19
IRINOTECAN KABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
Y
Y
Y
Y



iv
L01XX19
IRINOTECAN MYLAN 100 MG/5 ML conc for sol for inf
5 mL
-
iv
L01XX19
IRINOTECAN MYLAN 300 MG/15 ML conc for sol for inf
15 mL
15 mL
Y
-

iv
L01XX19
IRINOTECAN MYLAN 40 MG/2 ML conc for sol for inf
2 mL
-
iv
L01XX19
IRINOTECAN MYLAN 500 MG/25 ML conc for sol for inf
25 mL
25 mL
-
Y

iv
L01XX19
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
2 mL
5 mL
-
-

iv
L01XX19
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
15 mL
25 mL
-
-

iv
L01XX19
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
7,5 mL
-
-
-
-
N
-





iv
L01XX19
IRINOTECAN VIANEX 100 MG/5 ML conc for sol for inf
5 mL
-
iv
L01XX19
IRINOTECAN VIANEX 40 MG/2 ML conc for sol for inf
2 mL
-
iv
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for disp for inf
10 mL
Y
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 20 MG/ML conc for sol for inf
15 mL
2 mL
5 mL
BE313485
BE181291
BE181273
-
-
-
IRINOKABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
BE422055
BE339771
BE422064
BE339805
-
-
-
-
IRINOLIQUID conc for sol for inf
15 mL
25 mL
5 mL
BE433422
BE433422
BE340444
-
-
-
IRINOLIQUID 150 MG/7,5 ML conc for sol for inf
7,5 mL
BE446213
-
IRINOLIQUID 40 MG/2 ML conc for sol for inf
2 mL
BE340435
-
IRINOMYLAN 20 MG/ML conc for sol for inf
2 mL
5 mL
BE425966
BE425975
-
-
IRINOSIN 20 MG/ML conc for sol for inf
15 mL
2 mL
2 mL
25 mL
25 mL
5 mL
5 mL
BE373825
BE316854
BE316854
BE331475
BE331475
BE316863
BE316863
-
-
-
-
-
-
-
IRINOTECAN AB 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
BE384657
BE316994
BE333121
BE317003
BE317003
-
-
-
-
-
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
50 mL
BE500817
BE500791
BE500826
BE500800
BE578506
-
-
-
-
-
IRINOTECAN EG 20 MG/ML conc for sol for inf
2 mL
5 mL
BE336673
BE336682
-
-
IRINOTECAN EG 20 MG/ML conc for sol for inj
15 mL
BE336691
-
IRINOTECAN HIKMA 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
BE534044
BE534026
BE534053
BE534035
-
-
-
-
IRINOTECAN HIKMA FARMACEUTICA 20 MG/ML conc for sol for inf
2 mL
25 mL
5 mL
BE336052
BE336077
BE336061
-
-
-
IRINOTECAN KABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
BE371043
BE331825
BE371052
BE331834
-
-
-
-
IRINOTECAN MYLAN 100 MG/5 ML conc for sol for inf
5 mL
BE329673
-
IRINOTECAN MYLAN 300 MG/15 ML conc for sol for inf
15 mL
15 mL
BE347916
BE347916
-
-
IRINOTECAN MYLAN 40 MG/2 ML conc for sol for inf
2 mL
BE329664
-
IRINOTECAN MYLAN 500 MG/25 ML conc for sol for inf
25 mL
25 mL
BE347925
BE347925
-
-
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
2 mL
5 mL
BE502773
BE502782
-
-
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
15 mL
25 mL
BE542880
BE542897
-
-
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
7,5 mL
BE368575
BE368541
BE368584
BE368557
BE368557
BE368566
-
-
-
-
-
-
IRINOTECAN VIANEX 100 MG/5 ML conc for sol for inf
5 mL
BE365163
-
IRINOTECAN VIANEX 40 MG/2 ML conc for sol for inf
2 mL
BE365154
-
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for disp for inf
10 mL
EU/1/16/1130/001
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
CAMPTO 20 MG/ML conc for sol for inf
15 mL
2 mL
5 mL
167,54
19,71
52,41
IRINOKABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
IRINOLIQUID conc for sol for inf
15 mL
25 mL
5 mL
IRINOLIQUID 150 MG/7,5 ML conc for sol for inf
7,5 mL
IRINOLIQUID 40 MG/2 ML conc for sol for inf
2 mL
IRINOMYLAN 20 MG/ML conc for sol for inf
2 mL
5 mL
IRINOSIN 20 MG/ML conc for sol for inf
15 mL
2 mL
2 mL
25 mL
25 mL
5 mL
5 mL
IRINOTECAN AB 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
167,54
19,71
279,26
52,41
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
50 mL
167,54
19,71
279,26
52,41
IRINOTECAN EG 20 MG/ML conc for sol for inf
2 mL
5 mL
IRINOTECAN EG 20 MG/ML conc for sol for inj
15 mL
IRINOTECAN HIKMA 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
IRINOTECAN HIKMA FARMACEUTICA 20 MG/ML conc for sol for inf
2 mL
25 mL
5 mL
19,71
279,26
52,41
IRINOTECAN KABI 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
167,54
19,71
279,26
52,41
IRINOTECAN MYLAN 100 MG/5 ML conc for sol for inf
5 mL
IRINOTECAN MYLAN 300 MG/15 ML conc for sol for inf
15 mL
15 mL
167,54
IRINOTECAN MYLAN 40 MG/2 ML conc for sol for inf
2 mL
IRINOTECAN MYLAN 500 MG/25 ML conc for sol for inf
25 mL
25 mL
279,26
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
2 mL
5 mL
IRINOTECAN QILU PHARMA SPAIN 20 MG/ML conc for sol for inf
15 mL
25 mL
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
15 mL
2 mL
25 mL
5 mL
5 mL
7,5 mL
IRINOTECAN VIANEX 100 MG/5 ML conc for sol for inf
5 mL
IRINOTECAN VIANEX 40 MG/2 ML conc for sol for inf
2 mL
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for disp for inf
10 mL
793,69
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 100 MG/5 ML conc for sol for inf
1 polipropilenska bottle sa 5 ml koncent
Rx
-
L01XX19
IRINOTESIN 100 MG/5 ML conc for sol for inf
1 glass bottle sa 5 ml koncentrata za so
Rx
-
L01XX19
IRINOTESIN 40 MG/2 ML conc for sol for inf
1 glass bottle sa 2 ml koncentrata za so
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 100 MG/5 ML conc for sol for inf
1 polipropilenska bottle sa 5 ml koncent
BIH-H-5147972-7
-
09-07-2018
08-07-2023
IRINOTESIN 100 MG/5 ML conc for sol for inf
1 glass bottle sa 5 ml koncentrata za so
BIH-H-3195123-0
-
22-09-2017
21-09-2022
IRINOTESIN 40 MG/2 ML conc for sol for inf
1 glass bottle sa 2 ml koncentrata za so
BIH-H-0308505-8
-
22-09-2017
21-09-2022
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Croatia (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 20 MG/ML conc for sol for inf
1 bočica 15 ml conc za otopinu
1 bočica 2 ml conc za otopinu
1 bočica 5 ml conc za otopinu
Y
Y
Y
Rx
Rx
Rx
-
L01XX19
IRINOTEKAN ACCORD 20 MG/ML conc for sol for inf
1 bočica 15 ml conc
1 bočica 2 ml conc
1 bočica 25 ml conc
1 bočica 5 ml conc
1 bočica 50 ml conc
Y
Y
Y
Y
Y
Rx
Rx
Rx
Rx
Rx
-
L01XX19
IRINOTEKAN KABI 20 MG/ML conc for sol for inf
1 bočica 15 ml conc
1 bočica 2 ml conc
1 bočica 25 ml conc
1 bočica 5 ml conc
Y
Y
Y
Y
Rx
Rx
Rx
Rx
-
L01XX19
IRINOTESIN 20 MG/ML conc for sol for inf
1 bočica 15 ml conc za otopinu
1 bočica 2 ml conc za otopinu
1 bočica 25 ml conc za otopinu
1 bočica 5 ml conc za otopinu
Y
Y
Y
Y
Rx
Rx
Rx
Rx
-
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL -
Y
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 20 MG/ML conc for sol for inf
1 bočica 15 ml conc za otopinu
1 bočica 2 ml conc za otopinu
1 bočica 5 ml conc za otopinu
HR-H-391779464-03
HR-H-391779464-01
HR-H-391779464-02
29-09-2016
29-09-2016
29-09-2016
IRINOTEKAN ACCORD 20 MG/ML conc for sol for inf
1 bočica 15 ml conc
1 bočica 2 ml conc
1 bočica 25 ml conc
1 bočica 5 ml conc
1 bočica 50 ml conc
HR-H-879693802-03
HR-H-879693802-01
HR-H-879693802-04
HR-H-879693802-02
HR-H-879693802-05
21-03-2019
21-03-2019
21-03-2019
21-03-2019
21-03-2019
15-07-2021
15-07-2021
15-07-2021
15-07-2021
15-07-2021
IRINOTEKAN KABI 20 MG/ML conc for sol for inf
1 bočica 15 ml conc
1 bočica 2 ml conc
1 bočica 25 ml conc
1 bočica 5 ml conc
HR-H-885268744-03
HR-H-885268744-01
HR-H-885268744-04
HR-H-885268744-02
29-08-2018
29-08-2018
29-08-2018
29-08-2018
IRINOTESIN 20 MG/ML conc for sol for inf
1 bočica 15 ml conc za otopinu
1 bočica 2 ml conc za otopinu
1 bočica 25 ml conc za otopinu
1 bočica 5 ml conc za otopinu
HR-H-810518111-03
HR-H-810518111-01
HR-H-810518111-04
HR-H-810518111-02
02-12-2020
02-12-2020
02-12-2020
02-12-2020
ONIVYDE PEGYLATED LIPOSOMAL -
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CANRI 20MG/ML conc for sol for inf
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
N
N
N
iv
L01XX19
IRINOTECAN ACCORDPHARMA 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X50ML
20MG/ML 1X5ML
20MG/ML 1X5ML
N
Y
Y
N
Y
Y
N
N
Y
iv
L01XX19
IRINOTECAN KABI 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 1X5ML
Y
N
Y
N
Y
N
Y
N
iv
L01XX19
IRINOTECAN MYLAN 20MG/ML conc for sol for inf
20MG/ML 10X15ML
20MG/ML 10X25ML
20MG/ML 10X2ML
20MG/ML 10X5ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 20X15ML
20MG/ML 20X25ML
20MG/ML 20X2ML
20MG/ML 20X5ML
20MG/ML 5X15ML
20MG/ML 5X25ML
20MG/ML 5X2ML
20MG/ML 5X5ML
N
N
N
N
N
N
Y
Y
N
N
N
N
N
N
N
N
iv
L01XX19
IRINOTECAN PHARMAGEN 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 5X5ML
Y
Y
Y
Y
N
iv
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4,3MG/ML conc for sol for inf
4,3MG/ML 1X10ML
N
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CANRI 20MG/ML conc for sol for inf
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
44/ 171/04-C
44/ 171/04-C
44/ 171/04-C
MRP/DCP
MRP/DCP
MRP/DCP
IRINOTECAN ACCORDPHARMA 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X50ML
20MG/ML 1X5ML
20MG/ML 1X5ML
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
44/ 319/16-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
IRINOTECAN KABI 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 1X5ML
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
44/ 006/09-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
IRINOTECAN MYLAN 20MG/ML conc for sol for inf
20MG/ML 10X15ML
20MG/ML 10X25ML
20MG/ML 10X2ML
20MG/ML 10X5ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 20X15ML
20MG/ML 20X25ML
20MG/ML 20X2ML
20MG/ML 20X5ML
20MG/ML 5X15ML
20MG/ML 5X25ML
20MG/ML 5X2ML
20MG/ML 5X5ML
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
44/ 011/09-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
IRINOTECAN PHARMAGEN 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 5X5ML
44/ 293/14-C
44/ 293/14-C
44/ 293/14-C
44/ 293/14-C
44/ 293/14-C
NP
NP
NP
NP
NP
ONIVYDE PEGYLATED LIPOSOMAL 4,3MG/ML conc for sol for inf
4,3MG/ML 1X10ML
EU/1/16/1130/001
ORP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
CANRI 20MG/ML conc for sol for inf
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
0
0
0
IRINOTECAN ACCORDPHARMA 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X50ML
20MG/ML 1X5ML
20MG/ML 1X5ML
11584,59
11584,59
19257,9
19257,9
648,34
648,34
0
1704,72
1704,72
13941,71
13941,71
22551,16
22551,16
914,11
914,11
2285,27
2285,27
IRINOTECAN KABI 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 1X5ML
11584,59
11584,59
19257,9
19257,9
1518,49
1518,49
3779,07
3779,07
13941,71
13941,71
22551,16
22551,16
2045,6
2045,6
4912,75
4912,75
IRINOTECAN MYLAN 20MG/ML conc for sol for inf
20MG/ML 10X15ML
20MG/ML 10X25ML
20MG/ML 10X2ML
20MG/ML 10X5ML
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 20X15ML
20MG/ML 20X25ML
20MG/ML 20X2ML
20MG/ML 20X5ML
20MG/ML 5X15ML
20MG/ML 5X25ML
20MG/ML 5X2ML
20MG/ML 5X5ML
0
0
0
0
0
0
918,71
2314,23
0
0
0
0
0
0
0
0
1271
3069,71
IRINOTECAN PHARMAGEN 20MG/ML conc for sol for inf
20MG/ML 1X15ML
20MG/ML 1X25ML
20MG/ML 1X2ML
20MG/ML 1X5ML
20MG/ML 5X5ML
6800
10800
808
1880
0
8503
13061,4
1124,86
2510,86
ONIVYDE PEGYLATED LIPOSOMAL 4,3MG/ML conc for sol for inf
4,3MG/ML 1X10ML
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (0)
No result.
Finland (0)
No result.
Hungary (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x50ml vial
1x5ml vial
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
-
L01XX19
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
1x25ml vial
1x2ml vial
1x5ml vial
N
N
N
Rx
Rx
Rx
parenteral
L01XX19
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x5ml vial
N
N
N
N
Rx
Rx
Rx
Rx
parenteral
L01XX19
ONIVYDE PEGILÁLT LIPOSZÓMÁS 4,3 MG/ML conc for sol for inf
1x10ml vial
N
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x50ml vial
1x5ml vial
OGYI-T-23076/03
OGYI-T-23076/04
OGYI-T-23076/01
OGYI-T-23076/05
OGYI-T-23076/02
17-08-2016
17-08-2016
17-08-2016
17-08-2016
17-08-2016
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
1x25ml vial
1x2ml vial
1x5ml vial
OGYI-T-20520/03
OGYI-T-20520/01
OGYI-T-20520/02
07-03-2008
07-03-2008
07-03-2008
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x5ml vial
OGYI-T-20569/03
OGYI-T-20569/04
OGYI-T-20569/01
OGYI-T-20569/02
29-05-2008
29-05-2008
29-05-2008
29-05-2008
ONIVYDE PEGILÁLT LIPOSZÓMÁS 4,3 MG/ML conc for sol for inf
1x10ml vial
EU/1/16/1130/001
14-10-2016
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x50ml vial
1x5ml vial
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
1x25ml vial
1x2ml vial
1x5ml vial
0
0
0
0
0
0
0
0
0
0
0
0
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1x15ml vial
1x25ml vial
1x2ml vial
1x5ml vial
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
ONIVYDE PEGILÁLT LIPOSZÓMÁS 4,3 MG/ML conc for sol for inf
1x10ml vial
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
Y
Rx
-
L01XX19
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
Y
Rx
-
L01XX19
IRINOTECAN KABI 20 MG/ML conc for sol for inf
N
Rx
-
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
N
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
11-08-2016
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
07-04-2008
IRINOTECAN KABI 20 MG/ML conc for sol for inf
09-12-2010
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
14-10-2016
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
41.347
41.347
IRINOTECAN ACTAVIS 20 MG/ML conc for sol for inf
8.297
8.297
IRINOTECAN KABI 20 MG/ML conc for sol for inf
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 20 MG/ML 20 MG/ML conc for sol for inf
Y
Rx
iv
L01XX19
IRINOTECAN HYDROCHLORIDE 20 MG/ML conc for sol for inf
Y
Rx
iv
L01XX19
IRINOTECAN HYDROCHLORIDE 20 MG/ML conc for sol for inf
Y
Rx
iv
L01XX19
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
N
Rx
iv
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4.3 MG/ML conc for sol for inf
-
Rx
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 20 MG/ML 20 MG/ML conc for sol for inf
PA0822/212/001
15-02-2008
IRINOTECAN HYDROCHLORIDE 20 MG/ML conc for sol for inf
PA2315/108/001
15-07-2016
IRINOTECAN HYDROCHLORIDE 20 MG/ML conc for sol for inf
PA1986/068/001
16-05-2008
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
PA0577/234/001
07-07-2017
ONIVYDE PEGYLATED LIPOSOMAL 4.3 MG/ML conc for sol for inf
EU/1/16/1130/001
14-10-2016
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN EBEWE 20 MG/ML conc for sol for inf
N1 (100 mg/5 ml) bottle
N1 (150 mg/7,5 ml) bottle
N1 (300 mg/15 ml) bottle
N1 (40 mg/2 ml) bottle
N1 (500 mg/25 ml) bottle
N10 (100 mg/5 ml) bottle
N10 (150 mg/7,5 ml) bottle
N10 (40 mg/2 ml) bottle
N5 (100 mg/5 ml) bottle
N5 (150 mg/7,5 ml) bottle
N5 (40 mg/2 ml) bottle
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
15 ml N1 vial
2 ml N1 vial
25 ml N1 vial
5 ml N1 vial
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN MYLAN [IRINOTECAN STRIDES] 20 MG/ML conc for sol for inf
2 ml N1 bottle
5 ml N1 bottle
Rx
Rx
iv
L01XX19
IRINOTECAN SEACROSS 20 MG/ML conc for sol for inf
15 ml N1 vial
2 ml N1 vial
25 ml N1 vial
5 ml N1 vial
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECANO HIKMA 20 MG/ML conc for sol for inf
2 ml N1 vial
Rx
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN EBEWE 20 MG/ML conc for sol for inf
N1 (100 mg/5 ml) bottle
N1 (150 mg/7,5 ml) bottle
N1 (300 mg/15 ml) bottle
N1 (40 mg/2 ml) bottle
N1 (500 mg/25 ml) bottle
N10 (100 mg/5 ml) bottle
N10 (150 mg/7,5 ml) bottle
N10 (40 mg/2 ml) bottle
N5 (100 mg/5 ml) bottle
N5 (150 mg/7,5 ml) bottle
N5 (40 mg/2 ml) bottle
LT/1/10/2019/004
LT/1/10/2019/007
LT/1/10/2019/010
LT/1/10/2019/001
LT/1/10/2019/011
LT/1/10/2019/006
LT/1/10/2019/009
LT/1/10/2019/003
LT/1/10/2019/005
LT/1/10/2019/008
LT/1/10/2019/002
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
27-05-2010
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
15 ml N1 vial
2 ml N1 vial
25 ml N1 vial
5 ml N1 vial
LT/1/09/1525/004
LT/1/09/1525/001
LT/1/09/1525/003
LT/1/09/1525/002
DCP
DCP
DCP
DCP
10-04-2009
10-04-2009
10-04-2009
10-04-2009
IRINOTECAN MYLAN [IRINOTECAN STRIDES] 20 MG/ML conc for sol for inf
2 ml N1 bottle
5 ml N1 bottle
LT/1/12/2918/001
LT/1/12/2918/002
DCP
DCP
27-04-2012
27-04-2012
IRINOTECAN SEACROSS 20 MG/ML conc for sol for inf
15 ml N1 vial
2 ml N1 vial
25 ml N1 vial
5 ml N1 vial
LT/1/11/2422/003
LT/1/11/2422/001
LT/1/11/2422/004
LT/1/11/2422/002
DCP
DCP
DCP
DCP
21-04-2011
21-04-2011
21-04-2011
21-04-2011
IRINOTECANO HIKMA 20 MG/ML conc for sol for inf
2 ml N1 vial
LT/L/19/1153/001
PI
16-12-2019
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (28)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 20 MG/ML (15ML VIAL) conc for sol for inf
Rx
-
L01XX19
CAMPTO 20 MG/ML (2ML VIAL) conc for sol for inf
Rx
-
L01XX19
CAMPTO 20 MG/ML (5ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN ACTAVIS 20MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN EBEWE - (15ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
Rx
-
L01XX19
IRINOTECAN EBEWE - (25ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
Rx
-
L01XX19
IRINOTECAN EBEWE - (2ML VIAL) CONCENTRATE FOR SOLN FOR INF 2 conc for sol for inf
Rx
-
L01XX19
IRINOTECAN EBEWE - (5ML VIAL) CONCENTRATE FOR SOLN FOR INF 2 conc for sol for inf
Rx
-
L01XX19
IRINOTECAN EBEWE - (7.5ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE 20 MG/ML (50ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE 20MG/ML (2ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE 20MG/ML (15ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE 20MG/ML (25ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE 20MG/ML (5ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLN FOR INF 20MG/M conc for sol for inf
Rx
-
L01XX19
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (15ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (25ML V conc for sol for inf
Rx
-
L01XX19
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (2ML VI conc for sol for inf
Rx
-
L01XX19
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (5ML VI conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN 20MG/ML, (15ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN 20 MG/ML, (2ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN 20MG/ML (25ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN 20MG/ML, (5ML VIAL) conc for sol for inf
Rx
-
L01XX19
IRINOTECAN MYLAN GENERICS 20MG/ML conc for sol for inf
Rx
-
L01XX19
IRINOTECAN STRIDES 20MG/ML conc for sol for inf
Rx
-
L01XX19
IRINTO 20MG/ML conc for sol for inf
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 20 MG/ML (15ML VIAL) conc for sol for inf
MA505/04703
07-05-2010
CAMPTO 20 MG/ML (2ML VIAL) conc for sol for inf
MA505/04701
15-05-2007
CAMPTO 20 MG/ML (5ML VIAL) conc for sol for inf
MA505/04702
15-05-2007
IRINOTECAN ACTAVIS 20MG/ML conc for sol for inf
MA651/00601
16-11-2007
IRINOTECAN EBEWE - (15ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
MA939/04204
04-03-2016
IRINOTECAN EBEWE - (25ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
MA939/04205
04-03-2016
IRINOTECAN EBEWE - (2ML VIAL) CONCENTRATE FOR SOLN FOR INF 2 conc for sol for inf
MA939/04201
04-03-2016
IRINOTECAN EBEWE - (5ML VIAL) CONCENTRATE FOR SOLN FOR INF 2 conc for sol for inf
MA939/04202
04-03-2016
IRINOTECAN EBEWE - (7.5ML VIAL) CONCENTRATE FOR SOLN FOR INF conc for sol for inf
MA939/04203
04-03-2016
IRINOTECAN HYDROCHLORIDE 20 MG/ML (50ML VIAL) conc for sol for inf
MA1269/05105
24-03-2020
IRINOTECAN HYDROCHLORIDE 20MG/ML (2ML VIAL) conc for sol for inf
MA1269/05101
25-05-2016
IRINOTECAN HYDROCHLORIDE 20MG/ML (15ML VIAL) conc for sol for inf
MA1269/05103
25-05-2016
IRINOTECAN HYDROCHLORIDE 20MG/ML (25ML VIAL) conc for sol for inf
MA1269/05104
25-05-2016
IRINOTECAN HYDROCHLORIDE 20MG/ML (5ML VIAL) conc for sol for inf
MA1269/05102
25-05-2016
IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLN FOR INF 20MG/M conc for sol for inf
MA505/08903
11-12-2009
IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLN FOR INF 20MG/M conc for sol for inf
MA505/08901
11-12-2009
IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLN FOR INF 20MG/M conc for sol for inf
MA505/08902
11-12-2009
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (15ML conc for sol for inf
MA1123/01303
07-03-2012
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (25ML V conc for sol for inf
MA1123/01304
07-03-2012
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (2ML VI conc for sol for inf
MA1123/01301
07-03-2012
IRINOTECAN KABI 20MG/ML CONCENTRATE FOR SOLN FOR INF (5ML VI conc for sol for inf
MA1123/01302
07-03-2012
IRINOTECAN MYLAN 20MG/ML, (15ML VIAL) conc for sol for inf
MA1270/03103
18-07-2017
IRINOTECAN MYLAN 20 MG/ML, (2ML VIAL) conc for sol for inf
MA1270/03101
18-07-2017
IRINOTECAN MYLAN 20MG/ML (25ML VIAL) conc for sol for inf
MA1270/03104
12-06-2019
IRINOTECAN MYLAN 20MG/ML, (5ML VIAL) conc for sol for inf
MA1270/03102
18-07-2017
IRINOTECAN MYLAN GENERICS 20MG/ML conc for sol for inf
AA770/06801
23-07-2015
IRINOTECAN STRIDES 20MG/ML conc for sol for inf
MA910/00401
30-01-2013
IRINTO 20MG/ML conc for sol for inf
AA565/70201
15-06-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (0)
No result.
Norway (0)
No result.
Poland (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 100 MG/5 ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 5 ml
5 vial 5 ml
-
-
Lz
Lz
-
L01XX19
CAMPTO 20 MG/ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 15 ml
1 vial 2 ml
-
-
Lz
Lz
-
L01XX19
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
-
-
-
-
-
Lz
Lz
Lz
Lz
Lz
-
L01XX19
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
-
-
-
-
Lz
Lz
Lz
Lz
-
L01XX19
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
-
-
-
-
Rx
Rx
Rx
Rx
-
L01XX19
IRINOTECAN MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 5 ml
-
-
-
Lz
Lz
Lz
-
L01XX19
IRINOTECAN SUN 1,5 MG/ML sol for inf
1 worek 180 ml
1 worek 200 ml
1 worek 220 ml
1 worek 240 ml
10 bags 180 ml
10 bags 200 ml
10 bags 220 ml
10 bags 240 ml
5 bags 180 ml
5 bags 200 ml
5 bags 220 ml
5 bags 240 ml
-
-
-
-
-
-
-
-
-
-
-
-
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
-
L01XX19
IRINOTECAN-EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 7,5 ml
10 vial 2 ml
10 vial 5 ml
10 vial 7,5 ml
5 vial 2 ml
5 vial 5 ml
5 vial 7,5 ml
-
-
-
-
-
-
-
-
-
-
-
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
Lz
-
L01XX19
IRYNOTEKAN CHLOROWODORKU QILU 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
-
-
-
-
Lz
Lz
Lz
Lz
-
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 10 ml
-
-
Rx
Rx
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 100 MG/5 ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 5 ml
5 vial 5 ml
07522
07522
NP
NP
CAMPTO 20 MG/ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 15 ml
1 vial 2 ml
07521
07521
NP
NP
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
23432
23432
23432
23432
23432
DCP
DCP
DCP
DCP
DCP
22-09-2021
22-09-2021
22-09-2021
22-09-2021
22-09-2021
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
16093
16093
16093
16093
DCP
DCP
DCP
DCP
12-09-2019
12-09-2019
12-09-2019
12-09-2019
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
15869
15869
15869
15869
MRP
MRP
MRP
MRP
IRINOTECAN MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 5 ml
16473
16473
16473
DCP
DCP
DCP
IRINOTECAN SUN 1,5 MG/ML sol for inf
1 worek 180 ml
1 worek 200 ml
1 worek 220 ml
1 worek 240 ml
10 bags 180 ml
10 bags 200 ml
10 bags 220 ml
10 bags 240 ml
5 bags 180 ml
5 bags 200 ml
5 bags 220 ml
5 bags 240 ml
25912
25912
25912
25912
25912
25912
25912
25912
25912
25912
25912
25912
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
02-07-2025
IRINOTECAN-EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 7,5 ml
10 vial 2 ml
10 vial 5 ml
10 vial 7,5 ml
5 vial 2 ml
5 vial 5 ml
5 vial 7,5 ml
18249
18249
18249
18249
18249
18249
18249
18249
18249
18249
18249
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
06-05-2020
IRYNOTEKAN CHLOROWODORKU QILU 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
23718
23718
23718
23718
DCP
DCP
DCP
DCP
10-11-2020
10-11-2020
10-11-2020
10-11-2020
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 10 ml
CP
CP
Product
Pack
SPC
PIL
Company
CAMPTO 100 MG/5 ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 5 ml
5 vial 5 ml
CAMPTO 20 MG/ML Koncentrat do sporządzania roztworu do wlewów dożylnych
1 vial 15 ml
1 vial 2 ml
IRINOTECAN ACCORD 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
IRINOTECAN KABI 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
IRINOTECAN MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 5 ml
IRINOTECAN SUN 1,5 MG/ML sol for inf
1 worek 180 ml
1 worek 200 ml
1 worek 220 ml
1 worek 240 ml
10 bags 180 ml
10 bags 200 ml
10 bags 220 ml
10 bags 240 ml
5 bags 180 ml
5 bags 200 ml
5 bags 220 ml
5 bags 240 ml
IRINOTECAN-EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
1 vial 7,5 ml
10 vial 2 ml
10 vial 5 ml
10 vial 7,5 ml
5 vial 2 ml
5 vial 5 ml
5 vial 7,5 ml
IRYNOTEKAN CHLOROWODORKU QILU 20 MG/ML conc for sol for inf
1 vial 15 ml
1 vial 2 ml
1 vial 25 ml
1 vial 5 ml
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 10 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
IRINOTECAN ACCORD 20 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
-
-
-
-
-
PR
PR
PR
PR
PR
-
L01XX19
IRINOTECAN KABI 20 MG/ML CONC. PT. SOL. PERF.
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
-
-
-
-
PR
PR
PR
PR
-
L01XX19
IRINOTECAN KOANAA 20 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna care contine 15
1 flac. din sticla bruna care contine 2
1 flac. din sticla bruna care contine 5
10 flac. din sticla bruna care contin 2
10 flac. din sticla bruna care contin 5
5 flac. din sticla bruna care contin 2 m
5 flac. din sticla bruna care contin 5 m
-
-
-
-
-
-
-
PR
PR
PR
PR
PR
PR
PR
-
L01XX19
IRINOTECAN SUN 1,5 MG/ML SOL. PERF.
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
-
-
-
-
-
-
-
-
-
-
-
-
PR
PR
PR
PR
PR
PR
PR
PR
PR
PR
PR
PR
-
L01XX19
IRINOTESIN 20MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna x 15 ml conc. p
1 flac. din sticla bruna x 2 ml conc. pt
1 flac. din sticla bruna x 25 ml conc. p
1 flac. din sticla bruna x 5 ml conc. pt
-
-
-
-
PR
PR
PR
PR
-
L01XX19
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML CONC. PT. DISPERSIE PERF.
1 flac. de sticla de tip I cu dop de clo
-
PR
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
IRINOTECAN ACCORD 20 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
1 flacon din sticla bruna de tip I, avân
-
-
-
-
-
IRINOTECAN KABI 20 MG/ML CONC. PT. SOL. PERF.
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
1 flacon din sticla bruna cu capacitatea
-
-
-
-
IRINOTECAN KOANAA 20 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna care contine 15
1 flac. din sticla bruna care contine 2
1 flac. din sticla bruna care contine 5
10 flac. din sticla bruna care contin 2
10 flac. din sticla bruna care contin 5
5 flac. din sticla bruna care contin 2 m
5 flac. din sticla bruna care contin 5 m
-
-
-
-
-
-
-
IRINOTECAN SUN 1,5 MG/ML SOL. PERF.
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
1 punga perfuzabila non-PVC prevazuta cu
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
10 pungi perfuzabile non-PVC prevazute
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
5 pungi perfuzabile non-PVC prevazute c
-
-
-
-
-
-
-
-
-
-
-
-
IRINOTESIN 20MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla bruna x 15 ml conc. p
1 flac. din sticla bruna x 2 ml conc. pt
1 flac. din sticla bruna x 25 ml conc. p
1 flac. din sticla bruna x 5 ml conc. pt
-
-
-
-
ONIVYDE PEGYLATED LIPOSOMAL 4,3 MG/ML CONC. PT. DISPERSIE PERF.
1 flac. de sticla de tip I cu dop de clo
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (11)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 100 MG/5 ML conc for sol for inf
1 vial 5 ml conc
-
Rx
parenteral
L01XX19
CAMPTO 20 MG/ML conc for sol for inf
1 polipropilensko vial 15 ml conc
1 polipropilensko vial 2 ml conc
1 polipropilensko vial 5 ml conc
N
N
N
Rx
Rx
Rx
iv
L01XX19
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial 2 ml conc
-
Rx
parenteral
L01XX19
IRINOTEKAN EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
T
T
T
Rx
Rx
Rx
iv
L01XX19
IRINOTEKAN HOSPIRA 20 MG/ML conc for sol for inf
1 vial 2 ml sol
1 vial 25 ml sol
1 vial 5 ml sol
-
-
-
Rx
Rx
Rx
iv
L01XX19
IRINOTEKAN PHARMASWISS 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
-
-
Rx
Rx
parenteral
L01XX19
IRINOTEKAN STRIDES ARCOLAB INTERNATIONAL 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
N
N
Rx
Rx
iv
L01XX19
IRINOTEKAN TEVA 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
5 vial 5 ml conc
-
N
N
N
-
Rx
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTEKAN VIPHARM 20 MG/ML conc for sol for inf
1 stekleno vial 2 ml conc
1 stekleno vial 5 ml conc
-
-
Rx
Rx
iv
L01XX19
IRINOTEKANIJEV KLORID LEK 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
-
-
Rx
Rx
iv
L01XX19
IRINOTEKANIJEV KLORID MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
-
-
-
Rx
Rx
Rx
parenteral
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 100 MG/5 ML conc for sol for inf
1 vial 5 ml conc
-
CAMPTO 20 MG/ML conc for sol for inf
1 polipropilensko vial 15 ml conc
1 polipropilensko vial 2 ml conc
1 polipropilensko vial 5 ml conc
103-95/2015-3
103-95/2015-3
103-95/2015-3
NP
NP
NP
25-09-2015
25-09-2015
25-09-2015
25-09-2015
25-09-2015
25-09-2015
25-09-2015
25-09-2015
25-09-2015
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial 2 ml conc
-
IRINOTEKAN EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
1011-82/2014-11
1011-82/2014-11
1011-82/2014-11
DCP
DCP
DCP
12-08-2015
12-08-2015
12-08-2015
IRINOTEKAN HOSPIRA 20 MG/ML conc for sol for inf
1 vial 2 ml sol
1 vial 25 ml sol
1 vial 5 ml sol
1011-113/2012-12
1011-113/2012-12
1011-113/2012-12
MRP
MRP
MRP
02-11-2017
02-11-2017
02-11-2017
IRINOTEKAN PHARMASWISS 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
-
-
IRINOTEKAN STRIDES ARCOLAB INTERNATIONAL 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
103-31/2016-3
103-31/2016-3
DCP
DCP
25-08-2016
25-08-2016
25-08-2016
25-08-2016
25-08-2016
25-08-2016
IRINOTEKAN TEVA 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
5 vial 5 ml conc
103-127/2020-3
103-127/2020-3
103-127/2020-3
103-127/2020-3
103-127/2020-3
DCP
DCP
DCP
DCP
DCP
21-01-2021
21-01-2021
21-01-2021
21-01-2021
21-01-2021
IRINOTEKAN VIPHARM 20 MG/ML conc for sol for inf
1 stekleno vial 2 ml conc
1 stekleno vial 5 ml conc
5363-U-I-715/10
5363-U-I-716/10
DCP
DCP
10-09-2012
10-09-2012
10-09-2012
10-09-2012
10-09-2012
10-09-2012
IRINOTEKANIJEV KLORID LEK 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
5363-I-615/14
5363-I-616/14
MRP
MRP
12-05-2014
12-05-2014
IRINOTEKANIJEV KLORID MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
-
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
CAMPTO 100 MG/5 ML conc for sol for inf
1 vial 5 ml conc
CAMPTO 20 MG/ML conc for sol for inf
1 polipropilensko vial 15 ml conc
1 polipropilensko vial 2 ml conc
1 polipropilensko vial 5 ml conc
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial 2 ml conc
IRINOTEKAN EBEWE 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
341,35
46,12
97,12
IRINOTEKAN HOSPIRA 20 MG/ML conc for sol for inf
1 vial 2 ml sol
1 vial 25 ml sol
1 vial 5 ml sol
IRINOTEKAN PHARMASWISS 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
IRINOTEKAN STRIDES ARCOLAB INTERNATIONAL 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
IRINOTEKAN TEVA 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
5 vial 5 ml conc
46,12
550,46
97,12
IRINOTEKAN VIPHARM 20 MG/ML conc for sol for inf
1 stekleno vial 2 ml conc
1 stekleno vial 5 ml conc
IRINOTEKANIJEV KLORID LEK 20 MG/ML conc for sol for inf
1 vial 2 ml conc
1 vial 5 ml conc
46,12
97,12
IRINOTEKANIJEV KLORID MEDAC 20 MG/ML conc for sol for inf
1 vial 15 ml conc
1 vial 2 ml conc
1 vial 5 ml conc
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 100 MG/5 ML, conc for sol for inf
1 vial of 5 ml
-
Rx
iv
L01XX19
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial of 2 ml
-
Rx
iv
L01XX19
IRINOTECAN COMBINO PHARM 20 MG/ML conc for sol for inf
1 vial of 5 ml
-
Rx
iv
L01XX19
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
-
-
-
-
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN KEWL 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
-
-
-
-
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
1 vial of 5 ml
-
Rx
iv
L01XX19
IRINOTECAN QILU 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
Y
Y
Y
Y
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
-
-
-
-
Rx
Rx
Rx
Rx
iv
L01XX19
IRINOTECAN TEVA 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
-
-
-
Rx
Rx
Rx
iv
L01XX19
ROBEMAR 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 5 ml
-
-
Rx
Rx
iv
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 100 MG/5 ML, conc for sol for inf
1 vial of 5 ml
61330
01-03-1997
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial of 2 ml
61329
01-03-1997
IRINOTECAN COMBINO PHARM 20 MG/ML conc for sol for inf
1 vial of 5 ml
72297
25-05-2010
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
70539
70539
70539
70539
27-01-2010
27-01-2010
27-01-2010
27-01-2010
IRINOTECAN KEWL 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
71509
71509
71509
71509
13-10-2009
13-10-2009
13-10-2009
13-10-2009
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
1 vial of 5 ml
71257
08-10-2009
IRINOTECAN QILU 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
81771
81771
81771
81771
17-02-2017
17-02-2017
17-02-2017
17-02-2017
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
70936
70936
70936
70936
07-10-2010
07-10-2010
07-10-2010
07-10-2010
IRINOTECAN TEVA 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
69799
69799
69799
12-05-2008
12-05-2008
12-05-2008
ROBEMAR 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 5 ml
70033
70033
14-08-2008
14-08-2008
Product
Pack
SPC
PIL
Company
CAMPTO 100 MG/5 ML, conc for sol for inf
1 vial of 5 ml
CAMPTO 40 MG/2 ML conc for sol for inf
1 vial of 2 ml
IRINOTECAN COMBINO PHARM 20 MG/ML conc for sol for inf
1 vial of 5 ml
IRINOTECAN FRESENIUS 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
IRINOTECAN KEWL 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
IRINOTECAN MYLAN 20 MG/ML conc for sol for inf
1 vial of 5 ml
IRINOTECAN QILU 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
IRINOTECAN SANDOZ 20 MG/ML conc for sol for inf
1 vial of 15 ml
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
IRINOTECAN TEVA 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 25 ml
1 vial of 5 ml
ROBEMAR 20 MG/ML conc for sol for inf
1 vial of 2 ml
1 vial of 5 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (0)
No result.
Switzerland (28)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAMPTO 100 MG/5 ML conc for sol for inf
-
A
-
L01XX19
CAMPTO 300 MG/15 ML conc for sol for inf
-
A
-
L01XX19
CAMPTO 40 MG/2 ML conc for sol for inf
-
A
-
L01XX19
IRINOTECAN ACCORD 100 MG/5 ML conc for sol for inf
-
A
-
L01XX19
IRINOTECAN ACCORD 300 MG/15 ML conc for sol for inf
-
A
-
L01XX19
IRINOTECAN ACCORD 40 MG/2 ML conc for sol for inf
-
A
-
L01XX19
IRINOTECAN ACCORD 500 MG/25 ML conc for sol for inf
-
A
-
L01XX19
IRINOTECAN FRESENIUS 100 MG/5 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN FRESENIUS 300 MG/15 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN FRESENIUS 40 MG/2 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN FRESENIUS 500 MG/25 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN LABATEC 100 MG/5 ML solution à diluer pour perfusion
-
A
-
L01XX19
IRINOTECAN LABATEC 300 MG/15 ML solution à diluer pour perfusion
-
A
-
L01XX19
IRINOTECAN LABATEC 40 MG/2 ML solution à diluer pour perfusion
-
A
-
L01XX19
IRINOTECAN LABATEC 500 MG/25 ML solution à diluer pour perfusion
-
A
-
L01XX19
IRINOTECAN MMPHARM 100 MG/5 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN MMPHARM 300 MG/15 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN MMPHARM 40 MG/2 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN MMPHARM 500 MG/25 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN SANDOZ ECO 100 MG/5 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN SANDOZ ECO 300 MG/15 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN SANDOZ ECO 40 MG/2 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN SANDOZ ECO 500 MG/25 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN-TEVA LIQUID 100 MG/5 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN-TEVA LIQUID 300 MG/15 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN-TEVA LIQUID 40 MG/2 ML Infusionskonzentrat
-
A
-
L01XX19
IRINOTECAN-TEVA LIQUID 500 MG/25 ML Infusionskonzentrat
-
A
-
L01XX19
ONIVYDE LIPOSOMAL PéGYLé 4.3 MG / ML dispersion à diluer pour perfusion
-
A
-
L01XX19
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAMPTO 100 MG/5 ML conc for sol for inf
53470 2
Hauptzulassung
08-05-1998
28-03-2024
CAMPTO 300 MG/15 ML conc for sol for inf
53470 3
Hauptzulassung
08-05-1998
28-03-2024
CAMPTO 40 MG/2 ML conc for sol for inf
53470 1
Hauptzulassung
08-05-1998
28-03-2024
IRINOTECAN ACCORD 100 MG/5 ML conc for sol for inf
66766 2
Hauptzulassung
24-09-2018
23-09-2023
IRINOTECAN ACCORD 300 MG/15 ML conc for sol for inf
66766 3
Hauptzulassung
24-09-2018
23-09-2023
IRINOTECAN ACCORD 40 MG/2 ML conc for sol for inf
66766 1
Hauptzulassung
24-09-2018
23-09-2023
IRINOTECAN ACCORD 500 MG/25 ML conc for sol for inf
66766 4
Hauptzulassung
24-09-2018
23-09-2023
IRINOTECAN FRESENIUS 100 MG/5 ML Infusionskonzentrat
61246 2
Hauptzulassung
28-01-2011
IRINOTECAN FRESENIUS 300 MG/15 ML Infusionskonzentrat
61246 3
Hauptzulassung
28-01-2011
IRINOTECAN FRESENIUS 40 MG/2 ML Infusionskonzentrat
61246 1
Hauptzulassung
28-01-2011
IRINOTECAN FRESENIUS 500 MG/25 ML Infusionskonzentrat
61246 4
Hauptzulassung
28-01-2011
IRINOTECAN LABATEC 100 MG/5 ML solution à diluer pour perfusion
59284 2
Hauptzulassung
04-12-2009
IRINOTECAN LABATEC 300 MG/15 ML solution à diluer pour perfusion
59284 3
Hauptzulassung
04-12-2009
IRINOTECAN LABATEC 40 MG/2 ML solution à diluer pour perfusion
59284 1
Hauptzulassung
04-12-2009
IRINOTECAN LABATEC 500 MG/25 ML solution à diluer pour perfusion
59284 4
Hauptzulassung
04-12-2009
IRINOTECAN MMPHARM 100 MG/5 ML Infusionskonzentrat
59219 2
Exportzulassung
11-09-2009
10-09-2024
IRINOTECAN MMPHARM 300 MG/15 ML Infusionskonzentrat
59219 3
Exportzulassung
11-09-2009
10-09-2024
IRINOTECAN MMPHARM 40 MG/2 ML Infusionskonzentrat
59219 1
Exportzulassung
11-09-2009
10-09-2024
IRINOTECAN MMPHARM 500 MG/25 ML Infusionskonzentrat
59219 4
Exportzulassung
11-09-2009
10-09-2024
IRINOTECAN SANDOZ ECO 100 MG/5 ML Infusionskonzentrat
65645 2
Hauptzulassung
17-12-2014
IRINOTECAN SANDOZ ECO 300 MG/15 ML Infusionskonzentrat
65645 3
Hauptzulassung
17-12-2014
IRINOTECAN SANDOZ ECO 40 MG/2 ML Infusionskonzentrat
65645 1
Hauptzulassung
17-12-2014
IRINOTECAN SANDOZ ECO 500 MG/25 ML Infusionskonzentrat
65645 4
Hauptzulassung
17-12-2014
IRINOTECAN-TEVA LIQUID 100 MG/5 ML Infusionskonzentrat
59217 2
Hauptzulassung
06-05-2009
05-05-2024
IRINOTECAN-TEVA LIQUID 300 MG/15 ML Infusionskonzentrat
59217 4
Hauptzulassung
06-05-2009
05-05-2024
IRINOTECAN-TEVA LIQUID 40 MG/2 ML Infusionskonzentrat
59217 1
Hauptzulassung
06-05-2009
05-05-2024
IRINOTECAN-TEVA LIQUID 500 MG/25 ML Infusionskonzentrat
59217 3
Hauptzulassung
06-05-2009
05-05-2024
ONIVYDE LIPOSOMAL PéGYLé 4.3 MG / ML dispersion à diluer pour perfusion
65994 1
Hauptzulassung
25-07-2017
24-07-2022
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.